4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-17-040564
CIK 0001566373operating
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:48 PM ET
Size
5.5 KB
Accession
0001209191-17-040564
Insider Transaction Report
Form 4
Bates Jonathan
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-15+5,500→ 5,500 totalExercise: $14.27Exp: 2027-06-14→ Common Stock (5,500 underlying)
Footnotes (1)
- [F1]Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 15, 2017, the date of the Issuer's 2017 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:48 PM ET
- Size
- 5.5 KB